Call Us

0330 001 0048

ARTICLES

Arthrosamid^®’s story started two decades ago. The brainchild of the team at Contura, the product had been in human use for various indications since 2000, and a favourable safety profile had already been established.

IRELAND’S ORTHOPAEDICS MARKET IS SET TO EMBRACE ‘INNOVATIVE AND EXCITING’ TREATMENT TO HELP EASE PAIN CAUSED BY KNEE OSTEOARTHRITIS

Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection approved in Europe for the treatment of knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing osteoarthritis, which affects around one in four adults in Ireland aged over 601 (over 400,000 people)2 and current treatments are not long lasting or involve invasive knee replacement surgery. Despite a large suffering population, there has been very little innovation in the range of osteoarthritis treatments on offer to meaningfully help patients – until now.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their personal opinions and
professional experience. It does not necessarily represent the views of amsk.co.uk.
All guest submissions are published in good faith, and amsk.co.uk does not verify the accuracy of
claims, the clinical content, or the legal ownership of any images or media submitted.

The content is intended for general informational and educational purposes only. It does not
constitute medical advice and should not be used as a substitute for consultation with a qualified
healthcare professional. Readers should not rely on the information in this article to diagnose or
treat any medical condition. Always seek personalised medical guidance from a licensed clinician
before making health-related decisions.

The responsibility for ensuring that all text, data, and images comply with copyright, privacy, and
data protection laws lies solely with the article’s author. amsk.co.uk takes no responsibility for
third-party content and will act promptly to remove any material found to be inappropriate,
inaccurate, or in breach of regulations.

amsk.co.uk accept no liability for any loss, damage, or injury resulting from the use of or
reliance on content published on this site. By accessing this article, you agree to these terms.

If you believe this content breaches any rights or contains inaccurate information, please contact
us at [email protected].

Hyaluronic Acid: A Promising Path for Managing Knee Osteoarthritis and Supporting Cartilage Health

July 30, 2025 No Comments

Discover how hyaluronic acid injections are transforming knee osteoarthritis care. This innovative treatment not only relieves pain and improves joint mobility but also helps protect and potentially repair cartilage. Unlike traditional pain management therapies, hyaluronic acid restores the joint’s natural lubrication and cushioning, offering safe and lasting relief for people with osteoarthritis. Clinical research highlights low risk of side effects and sustained benefits, making hyaluronic acid a vital option for managing knee OA and delaying invasive surgery. Learn why hyaluronic acid is becoming a key player in the future of osteoarthritis treatment.

Methotrexate in Knee Osteoarthritis: Balancing Hope with Practical Challenges

July 30, 2025 No Comments

Methotrexate, a medication traditionally used for rheumatoid arthritis, is being explored as a treatment for knee osteoarthritis due to its inflammation-reducing properties. This article explains how methotrexate works, summarizes research on its effectiveness and safety for knee osteoarthritis, and discusses dosing challenges and side effects such as nausea and liver changes. Early studies suggest the drug may relieve symptoms and protect joint cartilage, but personalized dosing and regular monitoring are crucial to manage risks. Ongoing research and clinical trials are needed to clarify methotrexate’s long-term role in osteoarthritis care, highlighting the importance of balancing innovation with patient safety.

Contact Us

Useful Link

Product

Arthrosamid® is a registered trademark of Contura International Ltd. AMSK is not affiliated with or endorsed by Contura.